openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizie

News

Discover

Civics

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizie

New Journal

News

Discover

Civics

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

WHO Pauses Trial of Hydroxychloroquine in COVID-19 Patients Due to Safety Concerns — IJR News

WHO Pauses Trial of Hydroxychloroquine in COVID-19 Patients Due to Safety Concerns

Reporting

WHO Pauses Trial of Hydroxychloroquine in COVID-19 Patients Due to Safety Concerns

1 source·Updated May 26, 2020

The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday. Hydroxycholoroquine…

In this story:

Coverage details

No bias-rated sources yet

Other: 1

Total sources1

Last updatedMay 26, 2020

Does this breakdown look right?

Claim check

What each side asserts, disputes — or leaves out entirely.

Analyzing the coverage…

Where do you land?

Whose framing of this story rings truest to you?

Coverage

Independent Journal ReviewOtherWHO Pauses Trial of Hydroxychloroquine in COVID-19 Patients Due to Safety Concerns

Comments

Ask this story anything:

Free account · your comment posts right after signup

Pick a side

Best value email providers

Gmail

Outlook

708 votes · vote on the full ranking →